SlideChat is a multimodal generative artificial intelligence assistant for whole-slide computational pathology across cancer types

By: Ying Chen · Chenglong Ma · Qiongqiong Li · Fang Yan · Yirong Chen · Tianbin Li · Jin Ye · Ming Hu · Yuxiang Lin · Yanjun Li · Guoan Wang · Huihui Xu · Hui Dong · Xiang Wang · Xiaoxiao Xu · Yanyan Zhou · Xia Zhu · Sen Yang · Xiyue Wang · Lu Zhang · Yu Qiao · Rongshan Yu · Junjun He · Yuanfeng Ji

1 September 2026 at 08:00

Nature Cancer, Published online: 01 September 2026; doi:10.1038/s43018-026-01220-4

Chen et al. have developed SlideChat, a multimodal generative artificial intelligence assistant, which they benchmark on 27 pathology tasks across 33 cancer types. Expert pathologists rated the assistant as clinically relevant and accurate.

FGFR1 suppresses ovarian cancer progression by modulating SIRT3-dependent lactylation and metabolic reprogramming

Cell Death Discovery nature.com science feeds

By: Fan Jiang · Huaju Huang · Zhe Dong · Lu Zhang · Shiti Zhang · Mengnan Long · Xue Fan · Nan Li · Hao Ai

7 April 2026 at 08:00

Cell Death Discovery, Published online: 07 April 2026; doi:10.1038/s41420-026-03054-6

FGFR1 suppresses ovarian cancer progression by modulating SIRT3-dependent lactylation and metabolic reprogramming

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

Nature - Issue - nature.com science feeds

By: Jiawei Lv · Dan-Xue Zheng · Jin-Hui Liang · Ning Zhang · Zu-Lu Ye · Xu-Dong Xu · Melvin. L. K. Chua · Lu-Lu Zhang · Zi-Ming Du · Zi-Chen Zhang · Wen-Fei Li · Ling-Long Tang · Lei Chen · Yan-Ping Mao · Rui Guo · Yu-Pei Chen · Li Lin · Yuan Zhang · Xu Liu · Cheng Xu · Zhi-Xuan Li · Ling-Xin Xu · Pan-Yang Yang · Kun Chen · Deng Bin · Tian-Sheng Gao · Jian-Ye Yan · Lu-Si Chen · Shao Hui Huang · Hong-Yun Zhao · Shu-Bin Hong · Yu-Sheng Jie · Hui-Ling Huang · Xu-Hua Tang · Jing-Ping Yun · Li-Zhi Liu · Li Tian · Hao-Jiang Li · Ji-Bin Li · Guan-Qun Zhou · Jun Ma · Ying Sun

11 March 2026 at 08:00

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-w

A clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.

Reading view